VIDEO: ‘Promising’ treatment for alcoholic hepatitis in development

In this exclusive video, Steven Flamm, MD, chief of the liver program at the Northwestern Feinberg School of Medicine, discusses a potential treatment for alcoholic hepatitis that is currently in development.Although its been known for decades, there are no approved therapies for alcoholic hepatitis. Flamm said that 1-month mortality rates for patients with acute alcoholic hepatitis can be as high as 40%.Flamm said one drug currently in development, DUR-928 (Durect), has demonstrated good tolerability in previous research. He said that research presented at The Digital International LiverRead More

Share on facebook
Share on twitter
Share on linkedin